Skip to main content

Market Overview

Philippines, Moderna Reach 13M Vaccine Doses Supply Pact

  • Moderna Inc (NASDAQ: MRNA) has agreed to supply the Philippines government with 13 million doses of its COVID-19 vaccine.
  • Deliveries are set to begin in mid-2021.
  • The company's COVID-19 vaccine is not currently approved for use in the country, and it will work with regulators to pursue necessary approvals before distribution.
  • The company also anticipates a separate deal with the Philippines government and private sector to supply an additional 7 million doses.
  • The Philippines regulator has so far approved for emergency use COVID-19 vaccines developed by Pfizer Inc (NYSE: PFE)/BioNTech SE (NASDAQ: BNTX), AstraZeneca Plc (NASDAQ: AZN), and Sinovac Biotech (NASDAQ: SVA).
  • Price Action: MRNA shares are down 2.4% at $129.01 in premarket trading on the last check Monday.

Related Articles (PFE + MRNA)

View Comments and Join the Discussion!

Posted-In: COVID-19 VaccineBiotech News Health Care General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at